The case, which occurred in a Phase 1 trial of Moderna’s jab for the Epstein-Barr virus, will only add to the concerns around mRNA biotechnology and heart issues, particularly myocarditis.
This post was created with our nice and easy submission form. Create your post!
Comments
Loading…